vimarsana.com

Latest Breaking News On - Amphastar pharmaceuticals company profile - Page 1 : vimarsana.com

Amphastar Pharmaceuticals (NASDAQ:AMPH) Rating Reiterated by Needham & Company LLC

Needham & Company LLC reaffirmed their hold rating on shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) in a report released on Wednesday morning, Benzinga reports. A number of other equities research analysts also recently weighed in on AMPH. JPMorgan Chase & Co. began coverage on shares of Amphastar Pharmaceuticals in a research note on […]

Nations Financial Group Inc IA ADV Increases Stake in Amphastar Pharmaceuticals, Inc (NASDAQ:AMPH)

Nations Financial Group Inc. IA ADV boosted its holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 37.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,524 shares of the company’s stock after acquiring an additional 3,982 shares during the quarter. […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.